{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:06:22Z","timestamp":1789009582972,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cjco.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:08:26Z","timestamp":1778285306000},"page":"1166-1176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Historical Drug Costs Among Elderly Patients Hospitalized with Heart Failure in Canada, 2013-2014 to 2018-2019"],"prefix":"10.1016","volume":"8","author":[{"given":"Hena","family":"Qureshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Dover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanial M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McKelvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anique","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Patrice","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2239-3944","authenticated-orcid":false,"given":"Padma","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2026.05.001_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cjco.2024.11.019","article-title":"Economic burden of heart failure hospitalizations in Canada: a population-based study","volume":"7","author":"Ellis","year":"2025","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cjco.2022.04.011","article-title":"The state of heart failure care in Canada: minimal improvement in readmissions over time despite an increased number of evidence-based therapies","volume":"4","author":"Poon","year":"2022","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2026.05.001_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcdd6020019","article-title":"Cardiovascular risks associated with gender and aging","volume":"6","author":"Rodgers","year":"2019","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.cjco.2026.05.001_bib5","first-page":"1434","article-title":"Mind the gap: current challenges and future state of heart failure care","volume":"33","author":"McDonald","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.05.001_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4070\/kcj.2021.0401","article-title":"Medical management of patients with heart failure and reduced ejection fraction","volume":"52","author":"Greenberg","year":"2022","journal-title":"Korean Circ J"},{"key":"10.1016\/j.cjco.2026.05.001_bib7","first-page":"531","article-title":"CCS\/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction","volume":"37","author":"McDonald","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.05.001_bib8","first-page":"1342","article-title":"2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.05.001_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.919974","article-title":"Cost effectiveness analyses of pharmacological treatments in heart failure","volume":"13","author":"Lim","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cjco.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2007.11.006","article-title":"STROBE\u2014a checklist to Strengthen the Reporting of Observational Studies in Epidemiology","volume":"61","author":"Knottnerus","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cjco.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.cjco.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6963-8-12","article-title":"Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases","volume":"8","author":"Li","year":"2008","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cjco.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/aje\/154.9.854","article-title":"Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data","volume":"154","author":"Schneeweiss","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjco.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-020-05828-9","article-title":"Costs and healthcare utilisation of patients with heart failure in Spain","volume":"20","author":"Escobar","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cjco.2026.05.001_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3111\/13696998.2012.685136","article-title":"Resource utilization and costs following hospitalization of patients with chronic heart failure in the US","volume":"15","author":"Korves","year":"2012","journal-title":"J Med Econ"},{"key":"10.1016\/j.cjco.2026.05.001_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00516-2024","article-title":"20-year trends in excess costs of COPD","volume":"65","author":"Amegadzie","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjco.2026.05.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272638","article-title":"Economic burden of chronic pain in Alberta, Canada","volume":"17","author":"Thanh","year":"2022","journal-title":"PLOS One"},{"key":"10.1016\/j.cjco.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cjco.2020.03.015","article-title":"Optimal usage of sacubitril\/valsartan for the treatment of heart failure: the importance of optimizing heart failure care in Canada","volume":"2","author":"Huitema","year":"2020","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2026.05.001_bib24","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/j.jacc.2022.04.031","article-title":"Medicare coverage and out-of-pocket costs of quadruple drug therapy for heart failure","volume":"79","author":"Faridi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.05.001_bib25","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehi499","article-title":"Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure","volume":"26","author":"Lenzen","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2026.05.001_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1525-1497.1997.07105.x","article-title":"Differences in generalist and specialist physicians\u2019 knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure","volume":"12","author":"Chin","year":"1997","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cjco.2026.05.001_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ahj.2011.11.012","article-title":"Comparison of processes of care and clinical outcomes for patients newly hospitalized for heart failure attended by different physician specialists","volume":"163","author":"Boom","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2026.05.001_bib28","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure","volume":"40","author":"Lam","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2026.05.001_bib29","first-page":"S171","article-title":"Why is heart failure with preserved ejection fraction (HFpEF) more common in women than men? Exploring abnormalities in pulsitile arterial load as distinct feature of the hfpef syndrome in women","volume":"38","author":"Crosier","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.05.001_bib30","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.294.10.1240","article-title":"Risk-treatment mismatch in the pharmacotherapy of heart failure","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2026.05.001_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCOUTCOMES.109.879478","article-title":"Treatment and risk in heart failure: gaps in evidence or quality?","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjco.2026.05.001_bib32","first-page":"159","article-title":"CCS\/CHFS heart failure guidelines: clinical trial update on functional mitral regurgitation, SGLT2 inhibitors, ARNI in HFpEF, and tafamidis in amyloidosis","volume":"36","author":"O\u2019Meara","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.05.001_bib33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2026.05.001_bib36","first-page":"23","article-title":"The Role of GLP-1R and GIPR agonism in heart failure","volume":"3","author":"Sedrak","year":"2025","journal-title":"Can Diabetes Endocrinol Today"},{"key":"10.1016\/j.cjco.2026.05.001_bib37","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/biom15101403","article-title":"GLP-1 receptor agonists in heart failure","volume":"15","author":"Rahmani","year":"2025","journal-title":"Biomolecules"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X2600171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X2600171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:20:09Z","timestamp":1789006809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X2600171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589790X2600171X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2026.05.001","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Historical Drug Costs Among Elderly Patients Hospitalized with Heart Failure in Canada, 2013-2014 to 2018-2019","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}